172
Y. Gong et al. / Journal of Fluorine Chemistry 105 (2000) 169±173
3.2. Ethyl (Z)-3-phenyl-4,4,4-trifluorocrotonate (Z)-3a and
ethyl (Z)-2-phenyl-4,4,4-trifluorocrotonate (Z)-4a
0.0494 g) in anhydrous N,N-DMF (4.5 ml) was degassed
under a argon ¯ow for 5 min, and then heated with con-
tinuous stirring at 1208C for 30 h. The residue was puri®ed
on a silica gel column to afford 0.062 g of (Z)-3d (21.1%)
and 0.126 g of (Z)-4d (42.9%).
A
mixture of ethyl (E)-4,4,4-tri¯uorocrotonate
(1.0 mmol, 0.168 g), bromobenzene (2.0 mmol, 0.314 g),
diisopropylethylamine (2.0 mmol, 0.258 g), palladium acet-
ate (0.05 mmol, 0.0112 g), triphenylphophine (0.12 mmol,
0.0314 g) in anhydrous N,N-dimethylformamide (DMF,
4.5 ml) was degassed under a argon ¯ow for 5 min, and
then heated with continuous stirring at 1008C for 24 h. After
cooled, the reaction mixture was poured into a saturated
NH4Cl aqueous solution (20 ml). The aqueous layer was
extracted with ether (3Â20 ml), and the combined organic
phases were washed with saturated NH4Cl (aq), dried over
MgSO4, ®ltered, and concentrated at reduced pressure. The
residue was puri®ed on a silica gel column with hexane/ethyl
acetate (20:1, v/v) as the elution, to give 0.020 g of (Z)-3a
(8.0%) and 0.048 g of (Z)-4a (19.7%).
For (Z)-3d: 1H NMR (CDCl3) d: 7.84 (4H, m), 7.54 (3H,
m), 6.46 (1H, s), 4.33 (2H, q, J7.3 Hz), 1.36 (3H, t, J
7.3 Hz). 19F NMR (CDCl3) d: 102.07 (3F, s). MS (m/e): 294
(M , 81.3), 266 (15.4), 249 (41.6), 248 (100.0). HRMS Calc.
294.0868, Found: 294.0857.
For (Z)-4d: 1H NMR (CDCl3) d: 7.85 (4H, m), 7.53 (3H,
m), 6.15 (1H, q, J7.9 Hz), 4.42 (2H, q, J7.3 Hz), 1.37
(3H, t, J7.3 Hz). 19F NMR (CDCl3) d: 101.92 (3F, d, Jz
7.9 Hz). MS (m/e): 294 (M , 100.0), 265 (12.1), 249 (18.6),
221 (23.8), 201 (33.5). HRMS Calc. 294.0868, Found:
294.0870.
3.5. Ethyl (Z)-3-(4-chlorophenyl)-4,4,4-trifluorocrotonate
(Z)-3f and ethyl (Z)-2-(4-chlorophenyl)-4,4,4-
trifluorocrotonate (Z)-4f
For (Z)-3a: 1H NMR (CDCl3) d: 7.41 (5H, s), 6.33 (1H, s),
4.31 (2H, q, J7.2 Hz), 1.35 (3H, t, J7.2 Hz). 19F NMR
(CDCl3) d: 101.72 (3F, s). MS (m/e): 244 (M , 60.2), 215
(49.6), 199 (100.0), 171 (15.0). HRMS Calc. 244.0711,
4-Bromochlorobenzene (2.0 mmol, 0.383 g) was used
instead, and the reaction was done at 1208C for 24 h
according to the above procedure. The residue was puri®ed
on a silica gel column to give 0.047 g of (Z)-3f (16.9%) and
0.062 g of (Z)-4f (22.3%).
Found: 244.0713.
For (Z)-4a: 1H NMR (CDCl3) d: 7.42 (5H, s), 6.02 (1H, q,
J7.9 Hz), 4.37 (2H, q, J7.1 Hz), 1.35 (3H, t, J7.1 Hz).
19F NMR (CDCl3) d: 101.73 (3F, d, J7.9 Hz). MS (m/e):
244 (M , 100.0), 216 (24.9), 199 (31.3), 171 (95.8). HRMS
For (Z)-3f: 1H NMR (CDCl3) d: 7.36 (4H, s), 6.32 (1H, s),
4.32 (2H, q, J7.0 Hz), 1.35 (3H, t, J7.0 Hz). 19F NMR
Calc. 244.0711, Found: 244.0693.
(CDCl3) d: 101.65 (3F, s). MS (m/e): 278 (M , 46.8), 260
(92.5), 232 (100.0), 205 (78.3). HRMS Calc. 278.0321,
3.3. Ethyl (Z)-3-(4-anisyl)-4,4,4-trifluorocrotonate (Z)-3b
and ethyl (Z)-2-(4-anisyl)-4,4,4-trifluorocrotonate (Z)-4b
Found: 278.0309.
For (Z)-4f: 1H NMR (CDCl3) d: 7.38 (4H, s), 6.01 (1H, q,
J7.7 Hz), 4.36 (2H, q, J7.3 Hz), 1.35 (3H, t, J7.3 Hz).
19F NMR (CDCl3) d: 101.61 (3F, d, J7.7 Hz). MS (m/e):
4-Bromoanisole (2.0 mmol, 0.374 g) was used instead of
bromobenzene. The reaction was carried out at 1208C for
36 h, and worked-up similarly to give 0.054 g of (Z)-3b
(19.6%) and 0.072 g of (Z)-4b (26.2%).
278 (M , 95.4), 250 (41.9), 205 (100.0). HRMS Calc.
278.0321, Found: 278.0323.
For (Z)-3b: 1H NMR (CDCl3) d: 7.34 (2H, d, J8.8), 6.90
(2H, d, J8.8), 6.28 (1H, s), 4.29 (2H, q, J7.0 Hz), 3.83
(3H, s), 1.34 (3H, t, J7.0 Hz). 19F NMR (CDCl3) d: 101.72
3.6. Preparation of (E)-4a and (Z)-4a
(3F, s). MS (m/e): 274 (M , 100.0), 229 (61.5), 201 (9.7).
In a ¯ask, 20 ml of toluene and 1.2 g of clean sodium was
placed. The sodium is melted by means of an oil bath and the
stirrer is used to powder the sodium. After cooled, the
toluene is decanted. To the sodium 8.2 g (50 mmol) of ethyl
phenylacetate and 7.1 g (50 mmol) of ethyl tri¯uoroacetate
are slowly added at 0±58C. The mixture is heated with
vigorous stirring at 60±708C for 1 h, then chilled, acidi®ed
with 1 N HCl, extracted with ethyl acetate. The organic layer
is dried over calcium chloride, ®ltered, the solvent removed,
and the residue is distilled under reduced pressure to yield
2.9 g (22%) of ethyl 2-phenyl-4,4,4-tri¯uoroacetoacetate 7a,
bp 78±828C/10 mmHg.
HRMS Calc. 274.0817, Found: 274.0818.
For (Z)-4b: 1H NMR (CDCl3) d: 7.38 (2H, d, J8.8), 6.90
(2H, d, J8.8), 5.94 (1H, q, J7.9 Hz), 4.36 (2H, q, J
7.3 Hz), 3.82 (3H, s), 1.35 (3H, t, J7.3 Hz). 19F NMR
(CDCl3) d: 102.14 (3F, d, J7.9 Hz). MS (m/e): 274 (M ,
100.0), 229 (14.9), 201 (81.3). HRMS Calc. 274.0817,
Found: 274.0828.
3.4. Ethyl (Z)-3-(2-naphthyl)-4,4,4-trifluorocrotonate (Z)-
3d and ethyl (Z)-2-(2-naphthyl)-4,4,4-trifluorocrotonate
(Z)-4d
To a solution of 0.52 g of compound 7a (2.0 mmol) in
10 ml ethanol, 0.11 g of sodium borohydride (2.9 mmol)
is added in portion at room temperature. The mixture is
stirred for 2 h, then acidi®ed with 1 N HCl, extracted with
ethyl acetate. The crude product is puri®ed by silica gel
A
mixture of ethyl (E)-4,4,4-tri¯uorocrotonate
(1.0 mmol, 0.168 g), 2-bromonaphthalene (2.0 mmol,
0.414 g), diisopropylethylamine (2.0 mmol, 0.258 g), palla-
dium acetate (0.05 mmol, 0.0112 g), DPPP (0.12 mmol,